4//SEC Filing
von Moltke Lisa 4
Accession 0000950170-25-023569
CIK 0001609809other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:05 PM ET
Size
13.0 KB
Accession
0000950170-25-023569
Insider Transaction Report
Form 4
von Moltke Lisa
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2025-02-15+2,969→ 35,384 total - Exercise/Conversion
Common Stock
2025-02-15+8,907→ 44,291 total - Sale
Common Stock
2025-02-18$0.81/sh−4,416$3,579→ 39,875 total - Exercise/Conversion
Restricted Stock Units
2025-02-15−2,969→ 23,750 total→ Common Stock (2,969 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-15−8,907→ 26,718 total→ Common Stock (8,907 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 11, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units.
- [F3]The price reported in column 4 is a weighted average of the sale prices. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.8376, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.
- [F5]The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001808592
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:05 PM ET
- Size
- 13.0 KB